Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma

NCT00427414 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

14

Enrollment

NETWORK

Sponsor class

Stopped Terminated due to slow accrual.

Conditions

Sarcoma

Interventions

DRUG: liposomal daunorubicin citrate

Sponsor

AIDS Malignancy Consortium

Collaborators

[object Object]
[object Object]